Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- Clinical Study Details
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
-
Autoimmune Disorder -
Multiple Sclerosis (MS)
- Results
-
Download -
Study results
LPS MA30005 CASTING Final Results October 2020 Czech
(PDF, 0.6 MB)
LPS MA30005 CASTING Final Results October 2020 Danish
(PDF, 0.2 MB)
LPS MA30005 CASTING Final Results October 2020 Belgium Dutch
(PDF, 0.5 MB)
LPS MA30005 CASTING Final Results October 2020 Belgium French
(PDF, 0.5 MB)
LPS MA30005 CASTING Final Results October 2020 Italian
(PDF, 0.7 MB)
LPS MA30005 CASTING Final Results October 2020 Norwegian
(PDF, 0.7 MB)
LPS MA30005 CASTING Final Results October 2020 Spain Spanish
(PDF, 0.7 MB)
LPS MA30005 CASTING Final Results September 2021 English
(PDF, 2.1 MB)
LPS MA30005 CASTING Final Results December 2021 Switzerland French
(PDF, 0.6 MB)
LPS MA30005 CASTING Final Results December 2021 Switzerland German
(PDF, 0.4 MB)
LPS MA30005 CASTING Final Results September 2021 German
(PDF, 0.8 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com